<rst>
<header>
	<relations>
			<rel name="elaboration" type="rst"/>
			<rel name="background" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="manner" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">1. Introduction</segment>
<segment id="2" parent="1005" relname="span">Metabolic syndrome</segment>
<segment id="3" parent="2" relname="elaboration">( MetS )</segment>
<segment id="4" parent="1004" relname="same_unit">is a cluster of disorders , including insulin resistance/hyperglycemia , visceral adiposity</segment>
<segment id="5" parent="1007" relname="joint">[ identified by large waistline</segment>
<segment id="6" parent="1007" relname="joint">( WL )</segment>
<segment id="7" parent="1006" relname="joint">or being overweight ] ,</segment>
<segment id="8" parent="1009" relname="span">atherogenic dyslipidemia</segment>
<segment id="9" parent="1011" relname="span">( e. g. , raised triglycerides</segment>
<segment id="10" parent="9" relname="restatement">( TG )</segment>
<segment id="11" parent="1012" relname="span">or reduced high-density lipoprotein</segment>
<segment id="12" parent="11" relname="restatement">( HDL ) ) ,</segment>
<segment id="13" parent="1013" relname="span">and endothelial dysfunction</segment>
<segment id="14" parent="13" relname="elaboration">( characterized by elevated blood pressures ) .</segment>
<segment id="15" parent="1014" relname="joint">MetS significantly influences the development and deterioration of numerous diseases</segment>
<segment id="16" parent="1014" relname="joint">and is a crucial predictor of cardiovascular diseases .</segment>
<segment id="17" parent="1018" relname="span">Fortunately , numerous modifiable risk factors and corresponding practical intervention strategies</segment>
<segment id="18" parent="17" relname="elaboration">regarding MetS were proposed ,</segment>
<segment id="19" parent="1019" relname="span">and hence , it is vital to identify the high-risk individuals nowadays</segment>
<segment id="20" parent="19" relname="purpose">to prevent the incidence and deterioration of metabolic derangement and its associated diseases .</segment>
<segment id="21" parent="1021" relname="span">Nevertheless , the conventional procedures for the confirmation of MetS have depended on blood assays ,</segment>
<segment id="22" parent="1022" relname="joint">which largely lead to a resistive mentality toward the procedures</segment>
<segment id="23" parent="1022" relname="joint">and are therefore nonconducive to long-term follow-up .</segment>
<segment id="24" parent="1024" relname="span">Therefore , there is a high probability of the MetS population being under-identified ,</segment>
<segment id="25" parent="24" relname="elaboration">especially those without an obese body shape .</segment>
<segment id="26" parent="1026" relname="preparation">Consequently , there is a medical need for an easy , fast , and non-invasive method for MetS screening .</segment>
<segment id="27" parent="1028" relname="span">FibroScan is an ultrasound-based device</segment>
<segment id="28" parent="1031" relname="span">equipped with the naval patented technology — Vibration-Controlled Transient Elastography</segment>
<segment id="29" parent="28" relname="restatement">( VCTETM ) —</segment>
<segment id="30" parent="1031" relname="elaboration">that was originally developed</segment>
<segment id="31" parent="1032" relname="span">to assess the level of liver fibrosis and cirrhosis</segment>
<segment id="32" parent="1033" relname="span">by using a liver stiffness score</segment>
<segment id="33" parent="32" relname="elaboration">( the E score ) .</segment>
<segment id="34" parent="1034" relname="span">Based on the transformation function of media stiffness and wave transmission velocity ,</segment>
<segment id="35" parent="1035" relname="span">the E score is calculated</segment>
<segment id="36" parent="1036" relname="span">using a series of elastograms ,</segment>
<segment id="37" parent="1037" relname="span">which are simulated graphics of mathematical function of the time and depth of at least 10 shots of shear waves propagating through liver parenchyma</segment>
<segment id="38" parent="1038" relname="span">transmitted</segment>
<segment id="39" parent="1039" relname="span">using the probes</segment>
<segment id="40" parent="39" relname="elaboration">mounted on the device .</segment>
<segment id="41" parent="1041" relname="span">The multiple-shot shear wave and elastogram transformation are implemented with controlled vibration , energy , and algorithms on the identical volume of liver tissue</segment>
<segment id="42" parent="41" relname="purpose">to ensure measurement reliability .</segment>
<segment id="43" parent="1045" relname="span">The controlled attenuation parameter</segment>
<segment id="44" parent="43" relname="elaboration">( CAP )</segment>
<segment id="45" parent="1046" relname="span">score ,</segment>
<segment id="46" parent="45" relname="elaboration">denoting the liver steatosis ,</segment>
<segment id="47" parent="1047" relname="span">was embedded in instruments</segment>
<segment id="48" parent="47" relname="elaboration">marketed after 2013 .</segment>
<segment id="49" parent="1049" relname="span">The score is derived from the amplitude attenuations of ultrasonic waves</segment>
<segment id="50" parent="49" relname="elaboration">detected simultaneously from the E score measurement .</segment>
<segment id="51" parent="1052" relname="span">Owing to its merits</segment>
<segment id="52" parent="1053" relname="span">of being noninvasive , safe , rapid</segment>
<segment id="53" parent="52" relname="elaboration">( approximately 5 – 10 min for application ) ,</segment>
<segment id="54" parent="1054" relname="span">and the high-reproducibility of its automatically quantitative assessment outputs among operators , numerous studies have evaluated the performance of FibroScan</segment>
<segment id="55" parent="54" relname="elaboration">in detecting chronic hepatitis and various other liver disorders .</segment>
<segment id="56" parent="1026" relname="joint">In addition to bedside inspection in hospitalized patients , the virtue of its portability was also manifested in population outreach screening .</segment>
<segment id="57" parent="1058" relname="span">In a street-based screening for hepatitis C virus</segment>
<segment id="58" parent="57" relname="elaboration">( HCV )</segment>
<segment id="59" parent="1057" relname="same_unit">infection in drug users ,</segment>
<segment id="60" parent="1059" relname="joint">the maneuver was excellently accepted by the target population .</segment>
<segment id="61" parent="1059" relname="joint">Various studies have reported the liver steatosis grading cut-off points of CAP score in patients with different liver disorders with satisfactory accuracy .</segment>
<segment id="62" parent="1059" relname="joint">Overall , FibroScan has a multitude of merits , such as being noninvasive , safe , fast , convenient , portable , and highly accurate in the assessment of liver stiffness and steatosis .</segment>
<segment id="63" parent="1065" relname="attribution">A previous study found</segment>
<segment id="64" parent="1066" relname="span">that the grades</segment>
<segment id="65" parent="64" relname="elaboration">based on abdominal ultrasonography gave accurate information</segment>
<segment id="66" parent="1066" relname="elaboration">regarding liver steatosis and MetS in nonalcoholic , healthy people .</segment>
<segment id="67" parent="1067" relname="span">Moreover ,</segment>
<segment id="68" parent="1069" relname="span">considering the frequent coexistence and common pathological mechanisms of MetS and hepatopathy , such as steatohepatitis , liver inflammation , or the nonalcoholic fatty liver disease</segment>
<segment id="69" parent="68" relname="elaboration">( NAFLD ) ,</segment>
<segment id="70" parent="1070" relname="span">it was proposed</segment>
<segment id="71" parent="70" relname="elaboration">that liver steatosis , especially NAFLD , could be a hepatic manifestation of MetS .</segment>
<segment id="72" parent="1072" relname="span">Therefore , the FibroScan is investigated to be an option for the frontline screening of MetS in participants of a self-paid health examination in Taiwan .</segment>
<segment id="73" parent="1073" relname="span">To the best of our knowledge ,</segment>
<segment id="74" parent="1074" relname="span">this is the first study</segment>
<segment id="75" parent="1075" relname="span">to explore the utility of FibroScan</segment>
<segment id="76" parent="1076" relname="span">in identifying people from the general population</segment>
<segment id="77" parent="1077" relname="span">who have physical status and disorders</segment>
<segment id="78" parent="77" relname="elaboration">that fulfill the MetS criteria .</segment>
<segment id="79" parent="1078" relname="span">A subsequent objective was to explore its feasibility and reliability</segment>
<segment id="80" parent="1079" relname="span">in screening for MetS</segment>
<segment id="81" parent="80" relname="manner">without performing any simultaneous invasive procedures , such as blood assays .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1014" relname="background"/>
<group id="1003" type="span" parent="1002" relname="same_unit"/>
<group id="1004" type="multinuc" parent="1003" relname="span"/>
<group id="1005" type="span" parent="1004" relname="same_unit"/>
<group id="1006" type="multinuc" parent="1004" relname="evidence"/>
<group id="1007" type="multinuc" parent="1006" relname="joint"/>
<group id="1008" type="multinuc" parent="1002" relname="same_unit"/>
<group id="1009" type="span" parent="1008" relname="joint"/>
<group id="1010" type="multinuc" parent="8" relname="elaboration"/>
<group id="1011" type="span" parent="1010" relname="contrast"/>
<group id="1012" type="span" parent="1010" relname="contrast"/>
<group id="1013" type="span" parent="1008" relname="joint"/>
<group id="1014" type="multinuc" parent="1001" relname="span"/>
<group id="1018" type="span" parent="1014" relname="joint"/>
<group id="1019" type="span" parent="1014" relname="joint"/>
<group id="1021" type="span" parent="1014" relname="joint"/>
<group id="1022" type="multinuc" parent="21" relname="elaboration"/>
<group id="1024" type="span" parent="1014" relname="joint"/>
<group id="1025" type="span" parent="1014" relname="joint"/>
<group id="1026" type="multinuc" parent="1025" relname="span"/>
<group id="1027" type="span" parent="1026" relname="joint"/>
<group id="1028" type="span" parent="1027" relname="span"/>
<group id="1029" type="span" parent="27" relname="elaboration"/>
<group id="1030" type="span" parent="1029" relname="span"/>
<group id="1031" type="span" parent="1030" relname="span"/>
<group id="1032" type="span" parent="1030" relname="purpose"/>
<group id="1033" type="span" parent="31" relname="means"/>
<group id="1034" type="span" parent="1028" relname="elaboration"/>
<group id="1035" type="span" parent="34" relname="elaboration"/>
<group id="1036" type="span" parent="35" relname="means"/>
<group id="1037" type="span" parent="36" relname="elaboration"/>
<group id="1038" type="span" parent="37" relname="elaboration"/>
<group id="1039" type="span" parent="38" relname="means"/>
<group id="1041" type="span" parent="1026" relname="joint"/>
<group id="1043" type="multinuc" parent="1026" relname="joint"/>
<group id="1044" type="multinuc" parent="1043" relname="same_unit"/>
<group id="1045" type="span" parent="1044" relname="same_unit"/>
<group id="1046" type="span" parent="1044" relname="same_unit"/>
<group id="1047" type="span" parent="1043" relname="same_unit"/>
<group id="1049" type="span" parent="1026" relname="joint"/>
<group id="1051" type="multinuc" parent="1026" relname="joint"/>
<group id="1052" type="span" parent="1051" relname="same_unit"/>
<group id="1053" type="span" parent="51" relname="elaboration"/>
<group id="1054" type="span" parent="1051" relname="same_unit"/>
<group id="1056" type="span" parent="1026" relname="joint"/>
<group id="1057" type="multinuc" parent="1059" relname="preparation"/>
<group id="1058" type="span" parent="1057" relname="same_unit"/>
<group id="1059" type="multinuc" parent="1056" relname="span"/>
<group id="1063" type="span" parent="1059" relname="joint"/>
<group id="1064" type="span" parent="1063" relname="span"/>
<group id="1065" type="span" parent="1064" relname="span"/>
<group id="1066" type="span" parent="1065" relname="span"/>
<group id="1067" type="span" parent="1064" relname="elaboration"/>
<group id="1068" type="multinuc" parent="67" relname="elaboration"/>
<group id="1069" type="span" parent="1068" relname="same_unit"/>
<group id="1070" type="span" parent="1068" relname="same_unit"/>
<group id="1072" type="span" parent="1059" relname="joint"/>
<group id="1073" type="span" parent="72" relname="purpose"/>
<group id="1074" type="span" parent="73" relname="elaboration"/>
<group id="1075" type="span" parent="74" relname="purpose"/>
<group id="1076" type="span" parent="75" relname="elaboration"/>
<group id="1077" type="span" parent="76" relname="elaboration"/>
<group id="1078" type="span" parent="1059" relname="joint"/>
<group id="1079" type="span" parent="79" relname="elaboration"/>
	</body>
</rst>
